Good, validated antibodies are highly valuable, but hybridomas are easily lost. Storage accidents, genetic drift or contamination can threaten the security of your antibody.
One solution is to sequence your antibody to enable recombinant production. Sequencing an antibody is vital when obtaining intellectual property rights for your sequence, and expands your antibody’s potential with antibody engineering options.
Our hybridoma sequencing service is the starting point for protecting your antibody and embarking on antibody engineering projects such as species-, isotype- and subtype-switching or even humanization. For more information, please consult our hybridoma sequencing page or get in touch.
Sometimes however, it is too late for hybridoma sequencing as the cell line has been lost or otherwise unavailable. If sufficient protein is still available, advances in mass-spectrometry technology have made it possible to sequence the protein. For more information on this service, please refer to our antibody protein sequencing page or get in touch.